newsfilter
← Latest News
GlobeNewswire·

Otonomy to Host Virtual Investor R&D Event on March 22, 2022

SAN DIEGO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that it will host a virtual Investor R&D Event from 10 a.m.